【レポートの概要(一部)】
1. Report Overview
1.1 Overview of the World Market for Sexual Dysfunctions Treatment
1.2 Why You Should Read This Report
1.3 How This Study Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who is this Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Sexual Dysfunctions and Treatment Options
2.1 Diagnosis – ICD-10 and DSM-V
2.2 Male Sexual Dysfunctions
2.2.1 Sexual Desire Dysfunctions
2.2.2 Erectile Dysfunction
2.2.3 Priapism
2.2.4 Peyronie’s Disease
2.2.5 Premature Ejaculation
2.2.6 Hypogonadism
2.3 Female Sexual Dysfunctions
2.3.1 Dysfunctions of Arousal
2.3.2 Persistent Sexual Arousal Syndrome
2.3.3 Dysfunctions of Orgasm
2.3.4 Sexual Pain Dysfunctions
2.3.4.1 Dyspareunia
2.3.4.2 Vaginismus
2.3.5 Vulvodynia
3. The World Sexual Dysfunctions Drugs Market, 2015-2026
3.1 Global Sexual Dysfunctions Drugs Forecast 2015-2026
3.2 Sexual Dysfunction Drugs Market by Drug Class
3.2.1 PDE5 Inhibitors – Still Hold the Biggest Market Share
3.2.2 Prostaglandins – Dominated by Alprostadils
3.2.3 Androgens – Will New Delivery Technology Drive This Submarket?
3.2.4 Gonadotrophins – New Products Launched Expected
3.2.5 Other Drug Classes Market – Will See Significant Growth
3.3 Sexual Dysfunctions Drugs Market by Gender
3.3.1 Male Sexual Dysfunctions Drugs Market 2015-2026 – Declining as Originator Drugs Lose Patent Protection
3.3.2 Female Sexual Dysfunctions Drugs Market 2015-2026 – a Developing Market Holding Promising Commercial Potential
4. Sexual Dysfunction-Treating Drugs: Revenue Forecasts, 2015-2026
4.1 Cialis (Eli Lilly) – Faces Patent Expiry
4.2 Viagra (Pfizer) – Will Extended Patent in the US Protect Revenue?
4.3 Gonal-F (Merck KGaA) – Slow Growth in the First Half of the Forecast Period
4.4 Puregon (Merck & Co.) – Expected to Decline Significantly
4.5 Decapeptyl SR (Ipsen Ltd) – Growing Until the End of the First Half of the Forecast Period
4.6 Caverject Dual Chamber (Pfizer) – Growing During the First Half of the Forecast Period
4.7 Levitra (Bayer) – Sales Eroded by Cheaper PDE5 Inhibitors?
4.8 Nebido (Bayer) – Intramuscular Formulation of Testosterone Undecanoate
4.9 Testim (Ferring Pharmaceuticals) – Differentiated by Consistent Transdermal Absorption
4.10 Priligy (J&J/A. Menarini Pharma UK SRL) – SSRI to Treat Premature Ejaculation
4.11 Stendra/Spedra (VIVUS/Endo/Auxilium Pharmaceuticals) – Newest PDE5 Inhibitor
4.12 MUSE (Meda Pharmaceuticals) – Suppository Prostaglandin
4.13 Viridal Duo/Edex (UCB Pharma/Auxilium Pharmaceuticals) – Growing Strongly in the First Half of the Forecast Period
4.14 Tostran (ProStrakan Pharmaceuticals) – Eroded by Generic Competition Since 2014
4.15 Vitaros (Takeda) – Topical Formulation of Alprostadil
4.16 Restandol Testocaps (Merck & Co.) – Testosterone Replacement
4.17 Sustanon 250 (Aspen Pharma Trading) – Preferred Testosterone Replacement in the UK
4.18 Bemfola (Finox Biotech UK & Ireland Ltd.) – Biosimilar
4.19 Menopur (Ferring Pharmaceuticals) – a Preparation of Gonadotrophins
4.20 Pregnyl (Merck & Co.) – to Treat Hypogonadism
4.21 Androcur (Bayer Plc) – to Treat Androgen-related Conditions
4.22 Gonapeptyl (Ferring Pharmaceuticals) – Depot Injection
4.23 Intrinsa (Procter & Gamble) – Testosterone Patch
5. Emerging Therapies for Sexual Disorders
5.1 Vitaros (Takeda) – Topical Cream to Treat Erectile Dysfunction
5.2 Addyi (Sprout/Valeant Pharmaceuticals) – First Approved Drug for Female Sexual Dysfunction
5.3 Xiapex (Auxilium Pharmaceuticals)- First Approved Drug for Peyronie’s Disease
6. Leading Companies in the Sexual Dysfunction Drugs Market
6.1 Eli Lilly – Leading With Cialis
6.2 Pfizer – Will It Overtake Eli Lilly in This Forecast Period?
6.3 Merck KGaA – Driven by Sales in Emerging Markets
6.4 Merck & Co. – Will It Soon Lose Its Share to Competitors?
6.5 Ipsen Ltd – Ongoing Clinical Trials for Decapeptyl May Drive Further Growth
6.6 Bayer – Orodispersible Form of Levitra Not Pushing Revenue?
7. Leading National Markets: Revenue Forecasts, 2015-2026
7.1. The US Sexual Dysfunctions Drugs Market, 2015-2026 – Leader of the Pack
7.2. The Japanese Sexual Dysfunctions Drugs Market, 2015-2026 – Still Driven by Viagra and Cialis Sales
7.3 EU5 Sexual Dysfunctions Drugs Market, 2015-2026 – Cost Containment Will Slow the Market
7.4 BRIC Sexual Dysfunctions Drugs Market, 2015-2026 – Driven by Growth in China and India
7.5 Other Regions’ Sexual Dysfunctions Drugs Market, 2015-2026 – Expected High Growth Rate
8. R&D Pipelines for Sexual Dysfunctions Treatment
8.1 R&D Pipeline Drugs for Male Sexual Dysfunctions – Still Dominated by ED
8.1.1 Tissue Genesis Cell Isolation System (Tissue Genesis, Inc.) – ED
8.1.2 Adipose-Derived Stem Cell Injection (Ageless Regenerative Institute) – ED
8.1.3 Selegiline (University of South Florida) – ED
8.1.4 VL#FIA3-30 (VasoLead) – ED
8.1.5 MED2002 (Futura Medical) – ED
8.1.6 MED2005 (Futura Medical Developments Ltd) – ED
8.1.7 Fispemifene (NexMed) – ED and Secondary Hypogonadism
8.1.8 Transdermal Androgel (Johns Hopkins University) – Priapism
8.1.9 Adipose Tissue Stem Cell Injection (Man Clinic for Andrology, Male Infertility and Sexual Dysfunction) – Peyronie’s Disease
8.1.10 AA4500 and ErecAid Esteem Manual Vacuum Therapy System (Endo Pharmaceuticals) – Peyronie’s Disease
8.1.11 H-22411(Allergan) – Peyronie’s Disease
8.1.12 AA4500 (Allergan) – Peyronie’s Disease
8.1.13 IX-01 (Ixchelsis Limited) – Premature Ejaculation
8.1.14 CDFR0812-15 (CTC Bio, Inc.) – Premature Ejaculation
8.2 R&D Pipeline Drugs for Female Sexual Dysfunctions – Emerging Therapies
8.2.1 Tribulus Terrestris – Female Hypoactive Sexual Desire Disorder
8.2.2 Bremelanotide (Palatin Technologies) – Female Hypoactive Sexual Desire Disorder
8.2.3 Lybridos (Emotional Brain NY Inc.) – Female Hypoactive Sexual Desire Disorder
8.2.4 Lorexys (S1 Biopharma) – Female Hypoactive Sexual Desire Disorder
8.2.5 SST-6007 (Strategic Science & Technologies, LLC) – Female Hypoactive Sexual Desire Disorder
8.2.6 TBS-2 (Acerus Pharmaceuticals Corporation) – Orgasmic Disorder
8.2.7 SST-6006 (Strategic Science & Technologies, LLC) – Female Sexual Dysfunction
8.2.8 Fluocinonide Cream (OHSU Knight Cancer Institute National Cancer Institute (NCI)) – Painful Sexual Intercourse
9. Qualitative Analysis of the Sexual Dysfunctions Drugs Market 2015-2026
9.1 SWOT Analysis of the Sexual Dysfunctions Drugs Market, 2015-2026
9.1.1 Strengths
9.1.2 Weaknesses
9.1.3 Opportunities
9.1.4 Threats
9.2 STEP Analysis of the Sexual Dysfunctions Drugs Market, 2015-2026
9.2.1 Social
9.2.2 Technological
9.2.3 Economic
9.2.4 Political
10. Research Interviews from Our Survey – 2015
10.1 Dr. Carl Spana and Mr. Stephen Wills, Palatin Technologies
10.1.1 Palatin Technologies, Inc.
10.1.2 Female Sexual Dysfunction Market – What Are the Challenges?
10.1.3 Industry Effort to Bridge the Gaps
10.1.4 Drivers and Restraints of the FSD Market
10.1.5 Bremelanotide – On-Demand Treatment for HSDD
10.1.6 Designing Clinical Trials to Assess Drugs for FSDs – Remains a Challenge?
10.1.7 Commercial Potential of Bremelanotide
10.2 James Barder, CEO, Futura Medical
10.2.1 Futura Medical
10.2.2 Will the ED Treatment Market Show Growth?
10.2.3 Unmet Needs of ED Treatment and Management
10.2.4 MED2002 for ED – Targeted Delivery
10.2.5 DermaSys – Improves Permeation of APIs through the Skin
10.2.6 DermaSys –Therapeutic Benefits to Other Therapeutic Areas?
10.2.7 MED2002 – Could Potentially Meet the Unmet Demand in ED
11. Conclusions
11.1 Male Sexual Dysfunction Drugs Market
11.2 Female Sexual Dysfunction Drugs Market
11.3 Leading National Markets
11.4 Drugs in the Pipeline
【レポート販売概要】
■ タイトル:男性/女性性機能障害治療薬の世界市場2016-2026■ 英文:Male and Female Sexual Dysfunctions: Drug Market Report and Forecasts 2016-2026
■ 発行日:2015年12月
■ 調査会社:visiongain
■ 商品コード:VGAIN5122114
■ 調査対象地域:グローバル
- テレコムパワーソリューションの世界市場2019-2023About this market The growing adoption of hybrid telecom power systems will trigger the telecom power solutions market growth in the forthcoming years. The hybrid telecom power systems are witnessing a considerable rise in the adoption due to their several benefits over conventional systems. These systems offer reduced carbon footprint by the cell site, minimized operation and maintenance costs, a …
- 機能性粉末の世界市場予測:調理済み粉末、特殊粉末The global market for functional flours is projected to reach USD 78.00 Billion by 2022, growing at a CAGR of 7.82% from 2016, in terms of value, and 156.92 MT by volume by 2022. The rise in demand from industries such as bakery, R.T.E products, and soups & sauces is driving the functional flours market. Rise in consumer spending on processed food products is also estimated to be the key driving f …
- グローバル商用業航空宇宙市場におけるトップ10企業分析Synopsis The Strategic Defence Intelligence Global Top 10 Commercial Aerospace Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global commercial aerospace industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. General Elec …
- 地理空間イメージ分析の世界市場予測(~2021年)The geospatial imagery analytics market is estimated to grow from USD 2.77 Billion in 2016 to USD 10.21 Billion by 2021, at a high CAGR of 29.8% during the forecast period. Convergence and integration of geospatial analytics with IT, telecommunication, and the internet is considered to be one of the important factors responsible for the growing application and adaptability of geospatial imagery an …
- ビデオエンコーダの世界市場予測(~2023年):シングル、多重チャンネルThe video encoder market is expected to grow at a CAGR of 4.26% between 2017 and 2023; from USD 1.70 Billion in 2017 to USD 2.19 Billion by 2023. The growth of this market is being propelled by the growing deployment in broadcast and surveillance applications. The surveillance application includes different verticals such as retail, transportation, residential, commercial, institutional, and milit …
- 神経形態学的コンピューティングの世界市場分析:用途別(信号処理、画像処理、データ処理、物体検出、その他)、エンドユーザー別(家電、自動車、ヘルスケア、軍用、防衛など)、2024年までに6,480,100,000米ドルに達すると思われるThe neuromorphic computing market size is expected to reach USD 6,480.1 million by 2024 according to a new study by Grand View Research, Inc. The global neuromorphic computing market is expected to gain traction, owing to the rising demand for artificial intelligence. The prominent industry vendors are focusing on the development of neural processing units that can be incorporated into the process …
- 自動車窓および外部密封システムの世界市場予測(~2021):部品種類別(ガラスランチャンネル、ルーフモール、外装シール(前面ガラス、フードシール、トランクシール))、車両別(乗用車PC、小型商用車LCV、重型商用車HCV、電気自動車EV)、地域別“The global increase in vehicle production of fastest developing countries and developed countries gives the thrust for automotive sealant growth”The automotive window and exterior sealant market was estimated to be USD 18.26 billion in 2016 and is projected to reach USD 25.69 billion by 2021, with CAGR of 7.07%. The growth mainly contributes from global vehicle production of 92.6 million units in …
- 高解像度溶解分析の世界市場予測(~2021年)The global high-resolution melting analysis market is expected to reach USD 302.1 million by 2021 from USD 259.4 million in 2016, at a CAGR of 3.1% during the forecast period of 2016 to 2021. On the basis of product & service, the high-resolution melting analysis market is segmented into instruments, reagents & consumables, and software & services. The reagents and consumables segment dominated th …
- 世界のアナログIC市場動向(2014~2018)TechNavio's analysts forecast the Global Analog IC market to grow at a CAGR of 4.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need for power management in electronic products. The Global Analog IC market has also been witnessing the emerging applications of analog ICs in LED lighting systems. However, the demand and supply imbalance of anal …
- ウイスキーの世界市場:スコッチ・ウイスキー、アメリカン・ウイスキー、カナディアン・ウイスキー、アイリッシュ・ウイスキーAbout Whiskey The global whiskey market was the third largest segment in the global spirits market, accounting for 11.57% of the global spirits market in 2014. The global whiskey market comprises of five major segments: Scotch Whiskey, US whiskey, Canadian whiskey, Irish whiskey, and Other Whiskey. Technavio's analysts forecast the global whiskey market to grow at a CAGR 4.48% in terms of revenue …
- 自動車用ウルトラ・キャパシタの世界市場2016-2020About Automotive Ultra-capacitor An ultracapacitor is an energy storage device that stores energy through an electric field, whereas a battery stores and generates energy through a chemical reaction. Ultracapacitors can store higher charge quantity than batteries as they conduct electricity through an electric field, making them ideal for applications requiring high electric current and voltage. T …
- 世界のポリアミド市場Polyamide Market, by Types (PA 6, PA 6/6, Bio-based), applications (Automotive, Electrical & Electronics, Machinery, Consumer Goods, Textiles, Films & Coatings, Packaging, and others) & Geography - Global Trends & Forecasts to 2018 This report covers the major polyamide market including PA 6, PA 6/6, and Bio-based polyamide. It further divides the market on the basis of types, industry verticals, …
- 術中神経モニタリング(IONM)の世界市場の規模と予測:タイプ別(インソースIONM、アウトソースIONM)、地域別(北アメリカ[米国、カナダ]、ヨーロッパ[英国、ドイツ]、アジア太平洋[日本、中国]、ラテンアメリカ[ブラジル、メキシコ]、MEA [南アフリカ])、動向分析、2014-2025The global Intraoperative Neuromonitoring (IONM) market is expected to reach USD 3.6 billion by 2025, based on a new report by Grand View Research, Inc. The intraoperative neuromonitoring market is anticipated to witness significant growth in the forecast period, which can be attributed to the hospitals adopting intraoperative monitoring in a wide spectrum of surgeries. Major surgeries pose a risk …
- 直接給与生菌(DFM)の世界市場予測(~2022):種類別(乳酸菌類&バシラス属菌)、家畜別、形態別、地域別The direct-fed microbials market is projected to grow at a CAGR of 6.96% to reach USD 1,399.6 Million by 2022. The market is driven by factors such as increase in awareness about feed quality and safety, rising demand for manufactured animal feed, growth in demand for animal protein, changes in farming practices and technology, and replacing antibiotic growth promoters (AGPs) with direct-fed micro …
- 屋根用化学品の世界市場予測(~2021):メンブレンルーフィング、エラストマールーフィング、アスファルトルーフィング、金属ルーフィング、プラスチック(PVC)ルーフィングThe global roofing chemicals market is projected to reach USD 106.83 Billion by 2021, at a CAGR of 7.3% from 2016 to 2021. Roofing chemicals are experiencing a high demand from the construction sector in the Asia-Pacific region. Expansions and new product development activities undertaken by different companies for more energy efficient solutions are the key factors driving the growth of the globa …